Biomarker-based exclusion of ventilator-associated pneumonia: a multicentre validation study

Documenti analoghi

• Biomarkers for Ventilator-Associated Pneumonia: Review of the Literature
  di: Palazzo, Steven J., et al.
  Pubblicazione: (2011)
• Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial
  di: Hellyer, Thomas P., et al.
  Pubblicazione: (2016)
• Erratum to: ‘Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial’
  di: Hellyer, Thomas P., et al.
  Pubblicazione: (2016)
• Low-pathogenicity mycoplasma species induce immunoparesis and are highly prevalent amongst patients with ventilator-associated pneumonia
  di: Nolan, TJ, et al.
  Pubblicazione: (2015)
• Validation of the 2005 American Thoracic Society/Infectious Diseases Society of America guidelines for ventilator-associated pneumonia: a Japanese multicenter observational study
  di: Saito, N, et al.
  Pubblicazione: (2014)